Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 2
2005 3
2006 3
2007 2
2009 4
2010 2
2011 4
2012 3
2013 1
2014 1
2015 2
2016 1
2018 1
2019 1
2020 2
2021 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer.
Bardia A, Hurvitz SA, Tolaney SM, Loirat D, Punie K, Oliveira M, Brufsky A, Sardesai SD, Kalinsky K, Zelnak AB, Weaver R, Traina T, Dalenc F, Aftimos P, Lynce F, Diab S, Cortés J, O'Shaughnessy J, Diéras V, Ferrario C, Schmid P, Carey LA, Gianni L, Piccart MJ, Loibl S, Goldenberg DM, Hong Q, Olivo MS, Itri LM, Rugo HS; ASCENT Clinical Trial Investigators. Bardia A, et al. N Engl J Med. 2021 Apr 22;384(16):1529-1541. doi: 10.1056/NEJMoa2028485. N Engl J Med. 2021. PMID: 33882206 Clinical Trial.
Rationale and design of the Diet Restriction and Exercise-induced Adaptations in Metastatic breast cancer (DREAM) study: a 2-arm, parallel-group, phase II, randomized control trial of a short-term, calorie-restricted, and ketogenic diet plus exercise during intravenous chemotherapy versus usual care.
Kirkham AA, King K, Joy AA, Pelletier AB, Mackey JR, Young K, Zhu X, Meza-Junco J, Basi SK, Hiller JP, Brkin T, Michalowski B, Pituskin E, Paterson DI, Courneya KS, Thompson RB, Prado CM. Kirkham AA, et al. Among authors: meza junco j. BMC Cancer. 2021 Oct 10;21(1):1093. doi: 10.1186/s12885-021-08808-2. BMC Cancer. 2021. PMID: 34629067 Free PMC article.
Cholangiocarcinoma: has there been any progress?
Meza-Junco J, Montano-Loza AJ, Ma M, Wong W, Sawyer MB, Bain VG. Meza-Junco J, et al. Can J Gastroenterol. 2010 Jan;24(1):52-7. doi: 10.1155/2010/704759. Can J Gastroenterol. 2010. PMID: 20186357 Free PMC article. Review.
Trastuzumab for gastric cancer.
Meza-Junco J, Au HJ, Sawyer MB. Meza-Junco J, et al. Expert Opin Biol Ther. 2009 Dec;9(12):1543-51. doi: 10.1517/14712590903439702. Expert Opin Biol Ther. 2009. PMID: 19916733 Review.
[Molecular basis of cancer].
Meza-Junco J, Montaño-Loza A, Aguayo-González A. Meza-Junco J, et al. Rev Invest Clin. 2006 Jan-Feb;58(1):56-70. Rev Invest Clin. 2006. PMID: 16789600 Review. Spanish.
[Pathogenesis of portal hypertension].
Montaño-Loza A, Meza-Junco J. Montaño-Loza A, et al. Among authors: meza junco j. Rev Invest Clin. 2005 Jul-Aug;57(4):596-607. Rev Invest Clin. 2005. PMID: 16315644 Review. Spanish.
Uridine Glucuronosyltransferase 2B7 Polymorphism-Based Pharmacogenetic Dosing of Epirubicin in FEC Chemotherapy for Early-Stage Breast Cancer.
Joy AA, Vos LJ, Pituskin E, Cook SF, Bies RR, Vlahadamis A, King K, Basi SK, Meza-Junco J, Mackey JR, Stanislaus A, Damaraju VL, Damaraju S, Sawyer MB. Joy AA, et al. Among authors: meza junco j. Clin Breast Cancer. 2021 Oct;21(5):e584-e593. doi: 10.1016/j.clbc.2021.03.001. Epub 2021 Mar 6. Clin Breast Cancer. 2021. PMID: 33832852
34 results